AwardTape · Defense awards · Research and development · Health R&D · HT942523P0030
HT942523P0030: $1.0K purchase order to Genovac Antibody Discovery LLC
Genovac Antibody Discovery LLC holds a purchase order from Defense Health Agency with $1.0K obligated since Oct 2023 and $85K obligated over its life, against a ceiling of $85K. Latest action Mar 27, 2024.
Generation of monoclonal antibodies
| PIID | HT942523P0030 |
|---|---|
| Type | purchase order |
| Company | Genovac Antibody Discovery LLC |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN41 HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $1.0K |
| Total obligated (lifetime) | $85K |
| Ceiling (base and all options) | $85K |
| Base date | May 1, 2023 |
| Latest action | Mar 27, 2024 |
| End date | Dec 29, 2023 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | ND |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial